跳至主要内容
临床试验/CTRI/2018/01/011179
CTRI/2018/01/011179尚未招募2 期

A clinical evaluation of siddha drug Chitramutti Nei (Internal) in the treatment of Azhal Pandu (Iron deficiency anemia)

Ayothidoss Pandithar Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Hb level less than normal range, For male : 7-12gms/d1{13-18gms/d1}. For female :7-11gms /d1{11.5-16.5gms/d1}. Patient willing to undergo blood investigation. Patient willing to sign the informed consent stating that he/she will conscientiously stick to the treatment during 48days but can opt out of the trial of his/her own conscious discretion.

排除标准

  • Hypertension.pregnancy and lactation. presence of any associated severe systemic illness.(e.g. CA,RA) Endocrine disorder(Thyroid abnormality,Diabetes mellitus) Cardiac disease.Renal disease.Inherited defects (sickle cell anemia, Thalassemia,Aplastic anemia) Patient not willing to give blood sample. Epilepsy.Worm infestation.

研究者

发起方
Ayothidoss Pandithar Hospital

相似试验